Japanese Journal of Ophthalmology

, Volume 53, Issue 2, pp 176–179 | Cite as

Deepening of eyelid superior sulcus during topical travoprost treatment

  • Hee Kyung Yang
  • Ki Ho Park
  • Tae-Woo Kim
  • Dong Myung Kim
Brief Communication

Abstract

Background

Topical travoprost, a prostaglandin F (PGF) analog, has several well-known side effects, including a darkening of the eyelid and eyelash hypertrichosis, but there are no reports of a deepening of the eyelid superior sulcus associated with its use.

Cases

We examined one patient with unilateral normal-tension glaucoma and another with unilateral primary open-angle glaucoma, both of whom were treated with travoprost monotherapy unilaterally for 2 years.

Comments

Both patients gradually developed a deepening of the eyelid superior sulcus with hyperpigmentation in the eyelid skin of the treated eye. The disparity between the treated eye and the fellow eye was quite visible. However, the disparity returned to normal after discontinuation of travoprost for 15 months. A deepening of the eyelid superior sulcus is more significant in Asians, who seldom have an eyelid crease or deep sulcus. One proposed mechanism is a mechanical insult to the eyelid causing levator dehiscence. A second possible mechanism is fatty degeneration and reduced collagen fibers in the levator complex caused by the PGF analog. However, the exact mechanism remains to be determined.

Conclusion

A deepening of the eyelid superior sulcus should be considered a possible complication of topical travoprost that can be reversed by discontinuation of the medication.

Key Words

complications eyelid sulcus deepening travoprost 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Li N, Chen XM, Zhou Y, Wei ML, et al. Travoprost compared with other prostaglandin analogues or timolol in patients with openangle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol 2006;34:755–764.CrossRefGoogle Scholar
  2. 2.
    Peplinski LS, Albiani SK. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci 2004;81:574–577.PubMedCrossRefGoogle Scholar
  3. 3.
    Watanabe A, Araki B, Noso K, Kakizaki H, Kinoshita S. Histopathology of blepharoptosis induced by prolonged hard contact lens wear. Am J Ophthalmol 2006;141:1092–1096.PubMedCrossRefGoogle Scholar
  4. 4.
    Sagara T, Gaton, DD, Lindsey JD, et al. Topical prostaglandin F2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol 1 1999;117:794–801.Google Scholar
  5. 5.
    Bagwell JN, Davies DL, Ruby JR. The effects of prostaglandin F2α on the fine structure of the corpus luteum of the hysterectomized guinea pig. Anat Rec 1 1975;183:229–242.CrossRefGoogle Scholar

Copyright information

© Japanese Ophthalmological Society (JOS) 2009

Authors and Affiliations

  • Hee Kyung Yang
    • 1
    • 2
  • Ki Ho Park
    • 1
    • 2
    • 4
  • Tae-Woo Kim
    • 2
    • 3
  • Dong Myung Kim
    • 1
    • 2
  1. 1.Department of OphthalmologySeoul National University College of MedicineSeoulKorea
  2. 2.Seoul Artificial Eye CenterSeoul National University Hospital Clinical Research InstituteSeoulKorea
  3. 3.Department of OphthalmologySeoul National University Bundang HospitalSeongnamKorea
  4. 4.Department of OphthalmologySeoul National University College of MedicineSeoulKorea

Personalised recommendations